RECURSION PHARMACEUTICALS, INC. (26) | Business Operations (2)
- Form of Indemnification Agreement between the Registrant and each of its directors and executive officers (Filed With SEC on March 22, 2021)
- Research Collaboration and Option Agreement by and between Bayer AG and the Registrant, dated August 28, 2020 (Filed With SEC on March 22, 2021)